ICAD INC. - COMMON STOCK

iCAD Announces Leadership Transition

13 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists’ Efficiency and Accuracy

01 Mar 2023 08:00:02 By Nasdaq GlobeNewswire

iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

09 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI

23 Jan 2023 08:00:02 By Nasdaq GlobeNewswire

iCAD Announces Board of Directors Transition

11 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar

08 Dec 2022 08:00:02 By Nasdaq GlobeNewswire

iCAD and Google Health Ink Strategic Development and Commercialization Agreement

28 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection

21 Nov 2022 08:00:33 By Nasdaq GlobeNewswire

iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference

15 Nov 2022 16:13:15 By Nasdaq GlobeNewswire

iCAD to Present at HLTH 2022 With Google

14 Nov 2022 08:00:02 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Third Quarter Ended September 30, 2022

10 Nov 2022 16:03:15 By Nasdaq GlobeNewswire

iCAD to Join Forces with Radiology Partners, the Nation’s Largest Radiology Practice

10 Nov 2022 16:01:00 By Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022

27 Oct 2022 08:40:03 By Nasdaq GlobeNewswire

iCAD and Solis Mammography Ink Deal to Collaborate on Use of AI to Evaluate Risk of Cardiovascular Disease

11 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD To Participate in The Lake Street Capital Markets 6th Annual Best Ideas Growth (BIG6) Conference on September 14, 2022

07 Sep 2022 08:00:02 By Nasdaq GlobeNewswire

iCAD Customers in the U.S. and Europe Increasingly Adopting Company’s Full Suite of Breast AI Technologies via Subscription Model

29 Aug 2022 08:00:00 By Nasdaq GlobeNewswire

iCAD Reports Financial Results For Second Quarter 2022

10 Aug 2022 16:07:50 By Nasdaq GlobeNewswire

iCAD to Report Second Quarter 2022 Financial Results on August 10, 2022

27 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD Presents its Complete Suite of Breast Cancer AI Solutions at the European Congress of Radiology

13 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

ProFound AI Risk Real-World Case Studies to be featured in iCAD’s “ProFound Insights, ProFound Impact” Webinar Series

29 Jun 2022 08:00:01 By Nasdaq GlobeNewswire